Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Clonal heterogeneity of acute myeloid leukemia treated with the IDH2 inhibitor enasidenib.

Journal article

Quek L. et al, (2018), Nat Med, 24, 1167 - 1177

Single-cell analysis reveals the continuum of human lympho-myeloid progenitor cells.

Journal article

Karamitros D. et al, (2018), Nat Immunol, 19, 85 - 97

Identifying the optimum source of mesenchymal stem cells for use in knee surgery.

Journal article

Davies BM. et al, (2017), J Orthop Res, 35, 1868 - 1875

Enasidenib induces acute myeloid leukemia cell differentiation to promote clinical response.

Journal article

Amatangelo MD. et al, (2017), Blood, 130, 732 - 741

Mutational analysis of disease relapse in patients allografted for acute myeloid leukemia.

Journal article

Quek L. et al, (2016), Blood Adv, 1, 193 - 204

Load More